FEATURED
Sandoz Receives EC Approval for First Biosimilar for MS
The Biosimilar Tyruko® has been approved for all indications of reference medicine, as the first and only biosimilar to treat
DEALS
PeptiDream and Genentech Ink $1 Billion Deal for Peptide-RI Drug Conjugates
PeptiDream Inc., a publicly traded biopharmaceutical company headquartered in Kanagawa, Japan, led by President and CEO Patrick C. Reid, has
PRESS RELEASES
Yamaha Motor Opens New Company Specializing in Antibodies
Yamaha Motor Co., Ltd. announced today that the Company has established Tuning Fork Bio Inc. in Delaware, USA, with Chief
EDITOR’S PICKS
The Crucial Role of Heating Technology in Advancing Medical Devices
The current medical devices market boasts an impressive array of approximately 10,000 diverse types of equipment. Each individual device must
RESOURCES
Nucleosides, Nucleotides & Nucleic Acids Toolbox – Free E-Book – Biosynth
Nucleosides, Nucleotides & Nucleic Acids Toolbox A Biosynth .pdf E-Book Part 1 – Nucleosides and Nucleotides Chemistry, Structures, Modifications Analysis,
MANUFACTURING PROJECTS
Manufacturing Pharmaceuticals In Space
Varda Space Industries, a California-based startup, is venturing into the realm of pharmaceutical manufacturing in microgravity with the goal of
CLINICAL TRIALS
AstraZeneca’s Fasenra Achieves Primary Objective in Phase III Trial in EGPA
The MANDARA Phase III trial marks the first head-to-head comparison of biologics in treating eosinophilic granulomatosis with polyangiitis (EGPA), putting
REGULATORY
Sandoz Receives EC Approval for First Biosimilar for MS
The Biosimilar Tyruko® has been approved for all indications of reference medicine, as the first and only biosimilar to treat
SELECTED PRODUCTS
Stat6 (Phospho-Tyr641) Antibody
The Stat6 (Phospho-Tyr641) Antibody from Assay Biotechnology is a polyclonal antibody that specifically recognizes the phosphorylated form of Stat6 at
